NDUFA6
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 6
Also known as: B14, CI-B14, LYRM6, NADHB14, NDUA6_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P56556
- Gene
- NDUFA6
- Ensembl
- ENSG00000184983
- Chromosome
- 22
- Canonical length
- 128 aa
- Protein class
- Disease related genes, Human disease related genes, Metabolic proteins, Predicted intracellular proteins
- Subcellular location
- Nucleoplasm,Vesicles,Mid piece,End piece
OverviewNCBI Gene
This gene encodes a member of the LYR family of proteins that contain a highly conserved tripeptide (LYR) motif near the N-terminus. The encoded protein is an accessory subunit of NADH: ubiquinone oxidorerductase (Complex I), which is the largest enzyme of the mitochondrial membrane respiratory chain. Complex I functions in electron transfer from NADH to the respiratory chain. [provided by RefSeq, Oct 2016]
Canonical amino-acid sequenceUniProt
128 residues, UniProt reviewed canonical sequence.
>P56556|NDUFA6
1 MAGSGVRQAT STASTFVKPI FSRDMNEAKR RVRELYRAWY REVPNTVHQF QLDITVKMGR
61 DKVREMFMKN AHVTDPRVVD LLVIKGKIEL EETIKVWKQR THVMRFFHET EAPRPKDFLS
121 KFYVGHDPLocalizationUniProt · AlphaFold · HPA
Whether an antibody against NDUFA6 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Other membrane
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.43
- Highest tissue expression
- 260 nTPM
Expression across tissuesHPA
Tissue
- heart muscle: 260 nTPM
- skeletal muscle: 233 nTPM
- kidney: 136 nTPM
- liver: 115 nTPM
- parathyroid gland: 103 nTPM
- tongue: 94 nTPM
Single-cell type
- syncytiotrophoblasts: 638 nCPM
- parietal cells: 636 nCPM
- oocytes: 488 nCPM
- platelets: 472 nCPM
- hepatocytes: 466 nCPM
- esophageal apical cells: 421 nCPM
Immune cell
- total PBMC: 214 nTPM
- myeloid DC: 157 nTPM
- basophil: 128 nTPM
- eosinophil: 124 nTPM
- intermediate monocyte: 114 nTPM
- memory B-cell: 112 nTPM
Brain region
- choroid plexus: 16 nTPM
- pons: 8.7 nTPM
- thalamus: 6.8 nTPM
- hypothalamus: 6.7 nTPM
- medulla oblongata: 6.6 nTPM
- cerebral cortex: 6.4 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about NDUFA6.
Disease | AllUniProt
Conditions NDUFA6 is implicated in, by any mechanism.
- Mitochondrial complex I deficiency, nuclear type 33 (MC1DN33) MIM:618253
Disease | GeneticClinVar
7 pathogenic / likely-pathogenic of 88 ClinVar records.
Conditions with pathogenic or likely-pathogenic variants.
- Mitochondrial complex I deficiency, nuclear type 33
- Mitochondrial disease
- Inborn genetic diseases
- NDUFA6-related disorder
- Fetal anomalies with a likely genetic cause
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.71
- gnomAD pLI
- 0
- gnomAD missense Z
- -0.8
- DepMap mean gene effect
- -0.48
- DepMap dependency class
- selective
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 5% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- aerobic respiration
- mitochondrial electron transport, NADH to ubiquinone
- mitochondrial respiratory chain complex I assembly
- proton motive force-driven mitochondrial ATP synthesis
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Complex1_LYR-like
- NADH dehydrogenase [ubiquinone] (complex I), alpha subcomplex, subunit 6
- NDUFA6, LYR domain
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of NDUFA6 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads NDUFA6 as an antibody target. Whether an autoantibody or antibody against NDUFA6 could matter depends on whether native NDUFA6 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
NDUFA6 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label NDUFA6 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...